Found 136 matching trials
Response Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC PHASE2 The aim of this study is to develop an adaptive radiation therapy plan for ...
Show More Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS & PUMC
Learn More & Join Trial
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma PHASE2 The IO/TKI regimens which combines Immune checkpoint inhibitors (IO) with T...
Show More Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Learn More & Join Trial
HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma PHASE2 This clinical trial will evaluate a new combination of pembrolizumab, HPV-1...
Show More Location
UPMC Hillman Cancer Center
Learn More & Join Trial
QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma. PHASE3 The trial aimed to compare QL1706 combined with induction chemotherapy plus...
Show More Location
Fujian Cancer Hospital
Learn More & Join Trial
Neoadjuvant Short-course Radiotherapy Followed by the Combination of Immunotherapy and Chemotherapy in Locally Advanced Rectal Cancer PHASE2 This is a single arm, open-label, prospective phase II clinical trial to ev...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Sintilimab in Combination With Chemoradiotherapy in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma N/A The program aims to enroll patients with stage high risk (AJCC 8th, T3-4N2-...
Show More Location
Guangxi Medical University Cancer Hospital
Learn More & Join Trial
PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients PHASE2 Locally Advanced Anal Canal Squamous Carcinoma Patients will be enrolled an...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTL PHASE2 Aim of the trial is to evaluate the safety and efficacy of sintilimab and p...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer PHASE3 In order to further verify the effectiveness of the new prevention irradiat...
Show More Location
The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong 519000 Recruiting
Learn More & Join Trial
Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma PHASE3 Neoadjuvant chemotherapy combined with immunotherapy has achieved promising...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial